Franco Poletti - Dec 15, 2024 Form 4 Insider Report for LivaNova PLC (LIVN)

Role: President, Cardiopulmonary
Signature: /s/ Sarah K. Mohr, Attorney-in-Fact
Stock symbol: LIVN
Transactions as of: Dec 15, 2024
Transactions value $: -$21,424
Form type: 4
Date filed: 12/17/2024, 05:23 PM
Previous filing: Sep 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIVN	Ordinary Shares	Options Exercise	$0	+967	+14.5%	$0.00	7.63K	Dec 15, 2024	Direct	F1
transaction	LIVN	Ordinary Shares	Tax liability	-$21.4K	-416	-5.45%	$51.50	7.22K	Dec 15, 2024	Direct	F2
holding	LIVN	Ordinary Shares						219	Dec 15, 2024	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LIVN	Restricted Stock Units	Options Exercise	$0	-967	-50%	$0.00	967	Dec 15, 2024	Ordinary Shares	967		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.
F2	Shares withheld to satisfy tax liability.
F3	Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.
F4	On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.